Nanotechnology controlled drug delivery for treating bone diseases

Expert Opinion on Drug Delivery

Volumn 6, Issue 8, 2009, Pages 851-864

  Yang, Lei ^a   Webster, Thomas J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Bone diseases; Bone regeneration; Drug delivery; Implants; Nanotechnology; Tissue engineering

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; ALENDRONIC ACID; ANTIINFLAMMATORY AGENT; ARGINYLGLYCYLASPARTIC ACID; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CARBON NANOFIBER; CARBON NANOTUBE; CELECOXIB; FIBROBLAST GROWTH FACTOR; GENTAMICIN; HEPARIN; INDOMETACIN; IRON OXIDE; LIPOSOME; LYSINE; MACROGOL; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOSPHERE; NANOTUBE; PHOSPHOLIPID; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SELENIUM; SIMVASTATIN; TETRONIC; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BONE DISEASE; BONE REGENERATION; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; HUMAN; NANOTECHNOLOGY; NONHUMAN; REVIEW;

BONE DISEASES; BONE REGENERATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS; TISSUE SCAFFOLDS;

EID: 68149160162     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240903044935     Document Type: Review

References (112)

1. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polymer Edn 2007;18:241-268 •• A review of nanostructured drug delivery systems. (Pubitemid 46403135)
2. Anderson DG, Burdick JA, Langer R. Smart biomaterials. Science 2004;305:1923-1924
3. LaVan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003;21:1184-1191 (Pubitemid 37186175)
4. Bone diseases, Medline Plus. A service of the US National Library of Medicine and the National Institutes of Health. Available from: http://www.nlm.nih.gov/medlineplus/bonediseases.html#cat22 [Last accessed 16 February 2009]
5. National Osteoporosis Foundation. Available from: http://www.nof.org/ osteoporosis/diseasefacts.htm and http://www.nof.org/patientinfo/medications.htm [Last accessed 16 April 2009]
6. American Academy of Orthopedic Surgeons (AAOS). Available from: http://www.aaos. org/Research/stats/Arthritis.pdf [Last accessed 16 February 2009]
7. Prevalence and incidence of Paget's disease of bone. Available from: http://www. wrongdiagnosis.com/p/pagetbone/prevalence. htm [Last accessed 16 February 2009]
8. What are the key statistics about bone cancer, American Cancer Society. Available from: http://www.cancer.org/docroot/cri/content/cri-2-4-1x-what-are- the-key-statistics-for-bone-cancer-2.asp? [Last accessed 16 February 2009]
9. Paget's Disease of Bone. Available from: http://www.niams.nih.gov/Health- Info/Bone/Pagets/medical-treatment.asp [Last accessed 16 April 2009]
10. Ishizaki J, Waki Y, Takahashi-Nishioka T, et al. Selective drug delivery to bone using acidic oligopeptites. J Bone Miner Metab 2009;27:1-8
11. Ezra A, Golomb G. Administration routes and delivery systems of biosphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 2000;42:145-195
12. Anitua E, Sanchez M, Orive G, et al. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2007;29:37-41
13. Kim K, Fisher JP. Nanoparticle technology in bone tissue engineering. J Drug Target 2007;15:241-252 •• A review of nanoparticles in bone tissue engineering. (Pubitemid 47161492)
14. Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res 2006;23:1-30 • A review of polymeric structures for drug delivery.
15. Gonzalez B, Colilla M, Vallet-Regi M. Time-delayed release of bioencapsulates: a novel controlled delivery concept for bone implant technologies. Chem Mater 2008;20:4826-4834
16. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785-796
17. Liu H, Webster TJ. Bioinspired nanocomposites for orthopedic Applications. In: Webster TJ, editor, Nanotechnology for the Regeneration of Hard and Soft Tissues. Singapore: World Scientific; 2007. p. 1-52
18. Ishida O, Maruyama K, Sasaki K. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999;190:49-56 (Pubitemid 29467471)
19. Kong G, Braun RD, Dewhirst MW. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Res 2000;60:4440-4445 (Pubitemid 32103623)
20. Popat KC, Eltgroth M, LaTempa TJ, et al. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants? Small 2007;3:1878-1881
21. Sara ES, Chen J, Au L, et al. Gold nanocages for biomedical applications. Adv Mater 2007;19:3177-3184
22. Liu TY, Hu SH, Liu DM, et al. Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today 2009;4:52-65
23. Huang XH, EI-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128:2115-2120 (Pubitemid 43277351)
24. Sirivisoot S, Webster TJ. Multiwalled carbon nanotubes enhance electrochemical properties of titanium to determine in situ bone formation. Nanotechnology 2008;19:295101 (Pubitemid 351991641)
25. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 2005;11:1-8 • A review of protein adsorption on materials in cell process.
26. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-347 (Pubitemid 36297053)
27. Kujala S, Ryhanen J, Danilov A, et al. Effect of porosity on the osteointegration and bone ingrowth of a weight-bearing nickel-titanium bone graft substitute. Biomaterials 2003;24:4691-4697 (Pubitemid 37013630)
28. Mansouri S, Cuie Y, Winnik F, et al. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 2004;27:2060-2065 (Pubitemid 41759500)
29. McCarron PA, Marouf WM, Donnelly RF, et al. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res 2008;87A:873-884
30. Choi SW, Kim WS, Kim JH. Surface-functionalized nanoparticles for controlled drug delivery. Methods Mol Biol 2005;303:121-131
31. Choi SK, Kim JH. Design of surface-modified poly(D,L-lactide-co- glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007;122:24-30 (Pubitemid 47284550)
32. Gerwin N, Hops C, Lucke A. Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev 2006;58:226-242
33. Wang D, Miller SC, Kopeckova P, Kopecek J. Bone-targeting macromolecular therapeutics. Adv Drug Deliv Rev 2005;57:1049-1076 •• A review on water-soluble polymeric drug delivery systems specific for treating bone diseases.
34. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-131 (Pubitemid 32209236)
35. Liu H, Farrell S, Uhrich K. Drug release characteristics of unimolecular polymeric micelles. J Control Release 2000;68:167-174 (Pubitemid 30488894)
36. Riess G. Micellization of block copolymers. Prog Polym Sci 2003;28:1107-1170
37. Lee JS, Bae JW, Joung YK, et al. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 2008;346:57-63 (Pubitemid 350110508)
38. Nishiyama N, Kataoka K. Current state, achievement, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006;112:630-648 (Pubitemid 44592613)
39. Nishiyama N, Kataoka K. Nanostructured devices based on block copolymer assemblies for drug delivery: designing structures for enhanced drug formation. Adv Polym Sci 2006;193:67-101
40. Putman D. Polymers for gene delivery across length scales. Nat Mater 2006;5:439-451 (Pubitemid 43838906)
41. Li Y, Pei Y, Zhang X, et al. PEGylated PLGA nanoparticles as protein carrier: synthesis, preparation and biodistribution in rats. J Control Release 2001;71:203-211 (Pubitemid 32234381)
42. Jang JS, Kim SY, Lee SB, et al. Poly(ethylene glycol)/poly(ε- caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge groups and molecular weight in particle formation, cytotoxicity, and transfection. J Control Release 2006;113:173-182
43. Kushibiki T, Tabata Y. Preparation of poly(ethylene glycol) induced cationized gelatin as a non-vial gene carrier. J Biomater Sci Polym Ed 2005;16:1447-1461 (Pubitemid 44069680)
44. Cai Y, Pan H, Xu X, et al. Ultrasonic controlled morphology transformation of hollow calcium phosphate nanospheres: a smart and biocompatible drug release system. Chem Mater 2007;19:3081-3083 (Pubitemid 47150345)
45. Cai Y, Tang R. Calcium phosphate nanoparticles in biomineralization and biomaterials. J Mater Chem 2008;18:3775-3787
46. Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2003;36:R198-206
47. Xu C, Sun S. Monodisperse magnetic nanoparticles for biomedical applications. Polym Int 2007;56:821-826 (Pubitemid 46951862)
48. Balasundaram G, Webster TJ. Applications of magnetic nanoparticles for the treatment of osteoporosis. Mater Res Soc Symp Proc 2007;1019:1019-FF02-06
49. Pareta RA, Taylor E, Webster TJ. Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology 2008;19:265101 (Pubitemid 351813719)
50. Tran P, Sarin L, Hurt RH, et al. Titanium surfaces with adherent selenium nanoclusters as a novel anti-cancer orthopedic material. J Biomed Mater Res A (In press)
51. Navarro-Alarcon M, Lopez-Martinez MC. Essentiality of selenium in the human body: relationship with different diseases. Sci Total Environ 2000;249:347-371 (Pubitemid 30190303)
52. Kopeikin VV, Valueva SV, Kipper AI, et al. Synthesis of selenium nanoparticles in aqueous solutions of poly(vinylpyrrolidone) and morphological characteristics of the related nanocomposites. Polym Sci A 2003;45:374-379
53. Tran P, Webster TJ. Enhanced osteoblast adhesion on nanostructured selenium compacts for anti-cancer orthopedic applications. Int J Nanomed 2008;3:391-396
54. Nawroth T, Rusp M, May RP. Magnetic liposomes and entrapping: time-resolved neutron scattering TR-SANS and electron microscopy. Phys B Condens Matter 2004;350:E635-38 (Pubitemid 41066607)
55. Matsuo T, Sugita T, Kubo T, et al. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A 2003;66A:747-754 (Pubitemid 37521398)
56. Choi SK, Kim WS, Kim JH. Surface modification of functional nanoparticles for controlled drug delivery. J Disper Sci Technol 2003;24:475-487
57. Biondi M, Ungaro F, Qualia F, et al. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008;60:229-242 (Pubitemid 350236401)
58. Balasundaram G. Nanomaterials for better orthopedics. In: Webster TJ, editor, Nanotechnology for the regeneration of hard and soft tissues. Singapore: World Scientific; 2007. p. 53-78
59. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanostructured metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials 2004;19:4731-4739
60. Webster TJ, Ergun C, Doremus RH, et al. enhanced osteoblast functions on nanophase ceramics. J Biomed Mater Res 2000;51:475-479
61. Khang D, Lu J, Yao C, et al. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials 2008;29:970-983 (Pubitemid 50020176)
62. Tran P, Sarin L, Hurt R, et al. Promising orthopedic materials for bone cancer patient: Titanium coated with selenium nanoclusters. Proceeding of 34th Northeast Bioengineering Conference, Providence, USA; 2008. p. 262-263
63. Kim KH, Kwon TY, Kim SY, et al. Preparation and characterization of anodized titanium surfaces and their effect on osteoblast responses. J Oral Implantol 2006;32:8-13
64. Yao C, Webster TJ. Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. J Nanosci Nanotechnol 2006;6:2682-2692 (Pubitemid 44579939)
65. Yao C, Webster TJ. Anodization: a promising nano-modification technique of titanium implants for orthopedic applications. In: Webster TJ, editor, Nanotechnology for the Regeneration of Hard and Soft Tissues. Singapore: World Scientific; 2007. p. 79-106
66. Yao C, Perla V, McKenzie JL, et al. Anodized Ti and Ti6Al4V possessing nanometer surface features enhances osteoblast adhesion. J Biomed Nanotechnol 2005;66:68-73
67. Balasundaram G, Yao C, Webster TJ. TiO2 nanotubes functionalized with regions of bone morphogenetic protein-2 increases osteoblast adhesion. J Biomed Mater Res A 2007;84A:447-453
68. Popat KC, Eltgroth M, LaTempa TJ, et al. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007;28:4880-4888 (Pubitemid 47285337)
69. Chun AL, Moralez JG, Webster TJ, Fenniri H. Helical rosette nanotubes: a biomimetic coating for orthopedics. Biomaterials 2005;26:7304-7309 (Pubitemid 41135902)
70. Zhang LJ, Chen YP, Rodriguez J, et al. Biomimetic helical rosette nanotubes and nanocrystalline hydroxyapatite coatings on titanium for improving orthopedic implants. Int J Nanomed 2008 (In press)
71. Zhang LJ, Myles AJ, Fenniri H, Webster TJ. Novel biomimetic RGD modified hydrogels with improved cytocompatibility properties for bone tissue engineering applications. Biomaterials 2009 (In press)
72. Zhao B, Hu H, Mandal SK, et al. A bone mimic based on the self-assembly of hydroxyapatite on chemically functionalized single-walled carbon nanotubes. Chem Mater 2005;17:3235-3241 (Pubitemid 40850399)
73. Zanello LP, Zhao B, Hu H, et al. Bone cell proliferation on carbon nanotubes. Nano Lett 2006;6:562-567
74. Sirivisoot S, Yao C, Xiao X, et al. Greater osteoblast functions on multiwalled carbon nanotubes grown from anodized nanotubular titanium for orthopedic applications. Nanotechnology 2007;18:365102 (Pubitemid 47413701)
75. Kim JY, Khang D, Lee JE, et al. Decreased macrophage density on carbon nanotube patterns on polycarbonate urethane. J Biomed Mater Res A 2009;88A:419-426
76. Usui Y, Aoki K, Narita N, et al. Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects. Small 2008;4:240-246 (Pubitemid 351271157)
77. Kloss FR, Gassner R, Preiner J, et al. The role of oxygen termination of nanocrystalline diamond on immobilization of BMP-2 and subsequent bone formation. Biomaterials 2008;29:2433-2442
78. Yang L, Sheldon BW, Webster TJ. Orthopedic diamond coatings: control of surface properties and their impact on osteoblast adhesion and proliferation. J Biomed Mater Res A 2009 (In press), doi:10.1002/jbm.a.32227
79. Yang L, Sheldon BW, Webster TJ. The impact of diamond nanocrystallinity on osteoblast functions. Biomaterials 2009 (In press), doi: 10.1016/j. biomaterials.2009.03.014
80. Leach JK. Multifunctional cell-instructive materials for tissue regeneration. Regen Med 2006;1:447-455
81. Salvay DM, Shea LD. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst 2006;2:36-48
82. Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008;60:184-198
83. Piskin E, Isoglu A, Bolgen N, et al. In vivo performance of simvastatin-loaded electrospun spiral-wound polycaprolactone scaffolds in reconstruction of cranial bone defects in the rat model. J Biomed Mat Res A 2009 doi:10.1002/jbm.a.32157
84. Li C, Vepari C, Jin HJ, et al. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 2006;27(16):3115-3124 (Pubitemid 43247585)
85. Xu HHK, Weir MD, Simon CG. Injectable and strong nanoapatite scaffolds for cell/growth factor delivery and bone regeneration. Dental Mater 2008;24:1212-1222
86. Hosseinkhani H, Hosseinkhani M, Khademhosseini A, et al. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J Control Release 2007;117:380-386 (Pubitemid 46216579)
87. Jabbarzadeh E, Nair LS, Khan YM, et al. Apatite nano-crystalline surface modification of poly (lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering: implications for protein adsorption. J Biomater Sci Polymer Edn 2007;18:1141-1152 (Pubitemid 47556679)
88. Yoon JJ, Chung HJ, Lee HJ, et al. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res 2006;79:934-942
89. Jeon O, Song SJ, Kang SW, et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly (L-lactic-co-glycolic acid) scaffold. Biomaterials 2007;28:2763-2771 (Pubitemid 46413347)
90. Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008;29:4195-4204
91. Wei G, Ma PX. Nanostructured biomaterials for regeneration. Adv Funct Mater 2008;18:3568-3582
92. Wei G, Jin Q, Giannobile WV, et al. The enhancement of osteogenesis by nanofibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007;28:2087-2096 (Pubitemid 46198923)
93. Vogelson CT. Advances in drug delivery systems. Modern Drug Discov 2001;4:49-50
94. Feynman R. There's Plenty of Room at the Bottom. Lecture at an American Physical Society meeting, Caltech, CA. December 29, 1959
95. Taniguchi N. On the Basic Concept of Nano-Technology. Proc. Intl. Conf. Prod. London, Part II, British Society of Precision Engineering, 1974
96. Kayser O, Lemke A, Hernandez-Tejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005;(6):3-5 (Pubitemid 40246748)
97. Thomasin C, Corradin G, Ying M, et al. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly (lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J Control Release 1996;41:131-145 (Pubitemid 26246370)
98. Sanchez A, Gupta RK, Alonso MJ, et al. Pulsed controlled-released system for potential use in vaccine delivery. J Pharm Sci 1996;85:547-552 (Pubitemid 26179093)
99. Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 2002;7:569-579 (Pubitemid 34603648)
100. Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev 2001;46:125-148
101. Miyata T, Uragami T, Nakamae K. Biomolecule-sensitive hydrogels. Adv Drug Deliv Rev 2002;54:79-98
102. Berner B, Dinh SM. Electronically Controlled Drug Delivery, CRC Press, London, UK, 1998
103. Hafeli UO. Magnetically modulated therapeutic systems. Int J Pharm 2004;277:19-24
104. Southwood LL, Frisbie DD, Kawcak CE, et al. Delivery of growth factors using gene therapy to enhance bone healing. Vet Surg 2004;33:565-578
105. Rose FR, Hou Q, Oreffo RO. Delivery system for bone growth factors-the new players in skeletal regeneration. J Pharm Pharmacol 2004;56:415-427 (Pubitemid 38455606)
106. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005;84:1093-1103 (Pubitemid 43827776)
107. Rasubala L, Yoshikawa H, Nagata K, et al. Platelet-derived growth factor and bone morphogenetic protein in the healing of mandibular fractures in rats. Br J Oral Maxillofac Surg 2003;41:173-178 (Pubitemid 36874582)
108. Morishita N, Nakagami H, Morishita R, et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 2005;334:1121-1126 (Pubitemid 41074690)
109. Rozanova N, Zhang JZ. Metal and magnetic nanostructures for cancer detection, imaging and therapy. J Biomed Nanotechnol 2008;4:377-399
110. Glass GG. Osteoarthritis. Dis Mon 2006;52:343-362
111. Bone tumor. Available from: http:// orthoinfo.aaos.org/topic.cfm?topic = A00074&return-link = 0 [Last accessed 16 April 2009]
112. Win KY, Feng S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713-2722 (Pubitemid 39600724)